| RS2484708420 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS2484709149 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484709345 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS2484710174 |
COL1A2
|
Health Risk |
Likely pathogenic |
COL1A2-related disorder, COL1A2-related disorder |
| RS2484711152 |
COL1A2
|
Health Risk |
Likely pathogenic |
— |
| RS2484712486 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS2484712710 |
PEX1
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 1B, Peroxisome biogenesis disorder 1A (Zellweger) |
| RS2484712940 |
PEX1
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 1B, Peroxisome biogenesis disorder 1A (Zellweger) |
| RS2484713570 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484713607 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484713609 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484714499 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS2484714503 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484714527 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2484714900 |
RELN
|
Health Risk |
Pathogenic |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |
| RS2484716070 |
COL1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484716097 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS2484716719 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2484716722 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS2484716774 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484716827 |
COL1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484717396 |
GLI3
|
Health Risk |
Pathogenic |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS2484717434 |
GLI3
|
Health Risk |
Pathogenic |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS2484717536 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS2484719729 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484719766 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2484719924 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484721195 |
RELN
|
Health Risk |
Likely pathogenic |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |
| RS2484721766 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2484721857 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type III, Osteogenesis imperfecta type III |
| RS2484722803 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2484722826 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484722838 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type III, Osteogenesis imperfecta type III |
| RS2484723993 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2484724006 |
COL1A2
|
Health Risk |
Likely pathogenic |
— |
| RS2484724027 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484724068 |
COL1A2
|
Health Risk |
Likely pathogenic |
COL1A2-related disorder, COL1A2-related disorder |
| RS2484725181 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484725490 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2484725673 |
PEX1
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 1B, Peroxisome biogenesis disorder 1A (Zellweger) |
| RS2484725715 |
COL1A2
|
Health Risk |
Pathogenic |
COL1A2-related disorder, Osteogenesis imperfecta type I |
| RS2484725719 |
PEX1
|
Health Risk |
Pathogenic |
Heimler syndrome 1, Zellweger spectrum disorders |
| RS2484725756 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2484725787 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Heimler syndrome 1, Zellweger spectrum disorders |
| RS2484726009 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Heimler syndrome 1, Zellweger spectrum disorders |
| RS2484726023 |
PEX1
|
Health Risk |
Likely pathogenic |
Heimler syndrome 1, Heimler syndrome 1 |
| RS2484726571 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2484727900 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, cardiac valvular type |
| RS2484729335 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type III, Osteogenesis imperfecta type III |
| RS2484729358 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484729427 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484729507 |
COL1A2
|
Health Risk |
Pathogenic |
— |
| RS2484729533 |
COL1A2
|
Health Risk |
Likely pathogenic |
COL1A2-related disorder, COL1A2-related disorder |
| RS2484731890 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2484733399 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2484733748 |
GUSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS2484733750 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2484733902 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2484734326 |
GUSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS2484734370 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS2484734377 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS2484734390 |
GUSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS2484734751 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type III, Osteogenesis imperfecta type III |
| RS2484734805 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS2484734879 |
COL1A2
|
Health Risk |
Likely pathogenic |
COL1A2-related disorder, Ehlers-Danlos syndrome |
| RS2484735280 |
AUTS2
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder due to AUTS2 deficiency, Autism spectrum disorder due to AUTS2 deficiency |
| RS2484735314 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2484735353 |
TRRAP
|
Health Risk |
Likely pathogenic |
Hearing loss, autosomal dominant 75 |
| RS2484736269 |
COL1A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2484737317 |
COL1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS2484737368 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2484737404 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS2484737405 |
COL1A2
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, perinatal lethal |
| RS2484737456 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2484737558 |
COL1A2
|
Health Risk |
Likely pathogenic |
COL1A2-related disorder, COL1A2-related disorder |
| RS2484737562 |
COL1A2
|
Health Risk |
Likely pathogenic |
COL1A2-related disorder, COL1A2-related disorder |
| RS2484737810 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta with normal sclerae, dominant form |
| RS2484740883 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2484741062 |
RELN
|
Health Risk |
Pathogenic |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |
| RS2484741203 |
RELN
|
Health Risk |
Likely pathogenic |
— |
| RS2484743002 |
RELN
|
Health Risk |
Likely pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2484743799 |
COL1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, Osteogenesis imperfecta type I |
| RS2484748474 |
GUSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS2484748655 |
GUSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS2484749278 |
GUSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS2484750502 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS2484750954 |
RELN
|
Health Risk |
Pathogenic |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2484754163 |
IL2
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast neoplasm |
| RS2484759187 |
IL2
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast neoplasm |
| RS2484761266 |
AUTS2
|
Health Risk |
Pathogenic |
Autism spectrum disorder due to AUTS2 deficiency, Autism spectrum disorder due to AUTS2 deficiency |
| RS2484764776 |
GUSB
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2484765932 |
TRRAP
|
Health Risk |
Likely pathogenic |
— |
| RS2484765979 |
GUSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS2484774376 |
SEMA3A
|
Health Risk |
risk factor |
Hypogonadotropic hypogonadism 16 with or without anosmia, Hypogonadotropic hypogonadism 16 with or without anosmia |
| RS2484776976 |
TRRAP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2484780987 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS2484783425 |
ELN
|
Health Risk |
Likely pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS2484786284 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2484786829 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2484787497 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |